Concourse Financial Group Securities, Inc. Mainz Biomed N.V. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.2 - $0.48 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.38 - $1.13 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.88 - $1.2 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.04 - $3.15 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$2.89 - $4.9 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$2.89 - $4.9 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$3.42 - $6.49 $0 - $0
Q1 2023 May 15, 2023	BUY	$6.08 - $7.22 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$6.31 - $9.38 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$6.74 - $11.08 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$8.91 - $15.5 $0 - $0
Q1 2022 May 09, 2022	BUY	$10.39 - $27.76 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$8.05 - $26.46 $0 - $0

Others Institutions Holding MYNZ

# of Institutions

Shares Held

191K

Call Options Held

Put Options Held

View Full List

About MAINZ BIOMED N.V.

Ticker MYNZ
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 14,483,000
Market Cap $73.4M
Description
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...

More about MYNZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account